Cargando…

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype

Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Jessica L.L., Hickey, Theresa E., Warren, Anne Y., Vowler, Sarah L., Carroll, Tom, Lamb, Alastair D., Papoutsoglou, Nikolaos, Neal, David E., Tilley, Wayne D., Carroll, Jason S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051595/ https://www.ncbi.nlm.nih.gov/pubmed/24292680 http://dx.doi.org/10.1038/onc.2013.508

Ejemplares similares

FOXA1 mutations in hormone-dependent cancers
por: Robinson, Jessica L. L., et al.
Publicado: (2013)

FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
por: Robinson, Jessica L. L., et al.
Publicado: (2012)

SUN-003 Targeting Androgen Receptor-CXCR7-MARK Signaling Axis in CRPC
por: Gritsina, Galina, et al.
Publicado: (2019)

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor
por: Nikhil, Kumar, et al.
Publicado: (2020)

Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling
por: Glont, Silvia-E., et al.
Publicado: (2019)

Cooperativity and Equilibrium with FOXA1 Define the Androgen Receptor Transcriptional Program
por: Jin, Hong-Jian, et al.
Publicado: (2014)

Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide
por: Hong, Zhe, et al.
Publicado: (2021)

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
por: Asim, Mohammad, et al.
Publicado: (2015)

Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC)
por: Ryan, Charles J, et al.
Publicado: (2019)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH
por: Wang, Ranran, et al.
Publicado: (2015)

FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer
por: Gong, C, et al.
Publicado: (2015)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies
por: Hwang, Justin H, et al.
Publicado: (2022)

FoxA factors: the chromatin key and doorstop essential for liver development and function
por: Heslop, James A., et al.
Publicado: (2020)

Dynamic Chromatin Organization during Foregut Development Mediated by the Organ Selector Gene PHA-4/FoxA
por: Fakhouri, Tala H. I., et al.
Publicado: (2010)

FOXA1 is a critical determinant of Estrogen Receptor function and endocrine response
por: Hurtado, Antoni, et al.
Publicado: (2010)

Different chromatin-scanning modes lead to targeting of compacted chromatin by pioneer factors FOXA1 and SOX2
por: Lerner, Jonathan, et al.
Publicado: (2023)

Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties
por: Serandour, Aurelien A, et al.
Publicado: (2013)

Pre-marked chromatin and transcription factor co-binding shape the pioneering activity of Foxa2
por: Cernilogar, Filippo M, et al.
Publicado: (2019)

Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression
por: Cowper-Sal·lari, Richard, et al.
Publicado: (2012)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
por: Gao, Shuai, et al.
Publicado: (2020)

GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
por: Theodorou, Vasiliki, et al.
Publicado: (2013)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer
por: Alizadeh-Ghodsi, Mohammadreza, et al.
Publicado: (2022)

Expression and localisation of c-kit and KITL in the adult human ovary
por: Tuck, Astrud R, et al.
Publicado: (2015)

The molecular consequences of androgen activity in the human breast
por: Raths, Florian, et al.
Publicado: (2023)

A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1
por: Biernacka, K.M., et al.
Publicado: (2023)

Systematically understanding the immunity leading to CRPC progression
por: Ji, Zhiwei, et al.
Publicado: (2019)

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
por: Sharma, Naomi L., et al.
Publicado: (2014)

An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer
por: Heckman, Michael G., et al.
Publicado: (2016)

Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)
por: Bremmer, Felix, et al.
Publicado: (2014)

Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives
por: Taghizadeh, H., et al.
Publicado: (2019)

Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.
por: Hall, R. E., et al.
Publicado: (1996)

FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3
por: Jozwik, Kamila M., et al.
Publicado: (2016)

A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer
por: Warren, Anne Y., et al.
Publicado: (2018)

FOXA2 controls the anti-oxidant response in FH-deficient cells
por: Rogerson, Connor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mis2l3vb3uk2p3m8pqf3n4al9o